Masimo Co. (NASDAQ:MASI) Short Interest Update

Masimo Co. (NASDAQ:MASI) was the recipient of a large decrease in short interest in the month of December. As of December 31st, there was short interest totalling 2,740,000 shares, a decrease of 20.6% from the December 15th total of 3,450,000 shares. Approximately 5.6% of the company’s stock are sold short. Based on an average daily trading volume, of 561,600 shares, the days-to-cover ratio is presently 4.9 days.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. BTIG Research boosted their price target on shares of Masimo from $166.00 to $170.00 and gave the company a “buy” rating in a report on Monday, October 14th. Wells Fargo & Company boosted their target price on Masimo from $171.00 to $193.00 and gave the company an “overweight” rating in a research note on Wednesday, December 11th. Raymond James upped their target price on Masimo from $170.00 to $194.00 and gave the stock an “outperform” rating in a research report on Friday, December 27th. Piper Sandler lifted their price target on Masimo from $180.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, December 18th. Finally, Needham & Company LLC restated a “hold” rating on shares of Masimo in a report on Thursday. Three investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $179.67.

Institutional Investors Weigh In On Masimo

A number of hedge funds have recently bought and sold shares of MASI. NBC Securities Inc. lifted its position in shares of Masimo by 47.1% during the 3rd quarter. NBC Securities Inc. now owns 228 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 73 shares during the last quarter. MML Investors Services LLC increased its position in Masimo by 4.9% in the 3rd quarter. MML Investors Services LLC now owns 2,056 shares of the medical equipment provider’s stock worth $274,000 after buying an additional 96 shares during the period. UMB Bank n.a. lifted its holdings in shares of Masimo by 180.9% during the fourth quarter. UMB Bank n.a. now owns 191 shares of the medical equipment provider’s stock worth $32,000 after buying an additional 123 shares during the last quarter. Assetmark Inc. boosted its position in shares of Masimo by 12.7% in the third quarter. Assetmark Inc. now owns 1,183 shares of the medical equipment provider’s stock valued at $158,000 after acquiring an additional 133 shares during the period. Finally, Nordea Investment Management AB boosted its position in shares of Masimo by 0.7% in the fourth quarter. Nordea Investment Management AB now owns 19,182 shares of the medical equipment provider’s stock valued at $3,206,000 after acquiring an additional 142 shares during the period. 85.96% of the stock is currently owned by institutional investors.

Masimo Stock Up 1.4 %

Shares of NASDAQ:MASI traded up $2.35 on Friday, reaching $172.29. The company had a trading volume of 616,441 shares, compared to its average volume of 542,867. The company has a quick ratio of 1.11, a current ratio of 2.01 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $9.22 billion, a P/E ratio of 118.82 and a beta of 1.01. The stock has a 50-day moving average price of $169.03 and a 200 day moving average price of $139.75. Masimo has a twelve month low of $101.61 and a twelve month high of $180.97.

Masimo (NASDAQ:MASI) last posted its earnings results on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.14. Masimo had a return on equity of 14.98% and a net margin of 3.85%. The firm had revenue of $504.60 million during the quarter, compared to analyst estimates of $502.87 million. During the same period in the previous year, the company earned $0.63 EPS. The company’s revenue for the quarter was up 5.4% on a year-over-year basis. On average, equities analysts expect that Masimo will post 4.03 EPS for the current year.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.